ANAPTYSBIO, INC — Investor Relations & Filings
Filings indexed
636
across all filing types
Latest filing
2026-05-29
Regulatory Filings
Country
US
United States of America
Listing
US
ANAB
AnaptysBio, Inc. is a clinical-stage biotechnology company that focuses on the discovery and development of innovative immunology therapeutics. The company specializes in advancing immune cell-modulating antibodies designed to treat autoimmune and inflammatory diseases. Its therapeutic candidates target key pathways in the immune system to address significant unmet medical needs for various patient populations.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-29 | English | |
| 8-K | 2026-05-21 | English | |
| 8-K - ANAPTYSBIO, INC (0001370053) (Filer) | 2026-04-20 | English | |
| 4 - ANAPTYSBIO, INC (0001370053) (Issuer) | 2026-03-28 | English | |
| 8-K - ANAPTYSBIO, INC (0001370053) (Filer) | 2026-03-27 | English | |
| SCHEDULE 13G/A - ANAPTYSBIO, INC (0001370053) (Subject) | 2026-03-26 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47894171 | 8-K | 2026-05-29 | English | ||
| 46753425 | 8-K | 2026-05-21 | English | ||
| 34694408 | 8-K - ANAPTYSBIO, INC (0001370053) (Filer) | 2026-04-20 | English | ||
| 33067330 | 4 - ANAPTYSBIO, INC (0001370053) (Issuer) | 2026-03-28 | English | ||
| 33060272 | 8-K - ANAPTYSBIO, INC (0001370053) (Filer) | 2026-03-27 | English | ||
| 33051859 | SCHEDULE 13G/A - ANAPTYSBIO, INC (0001370053) (Subject) | 2026-03-26 | English | ||
| 32890702 | 10-K - ANAPTYSBIO, INC (0001370053) (Filer) | 2026-03-03 | English | ||
| 32890701 | 8-K - ANAPTYSBIO, INC (0001370053) (Filer) | 2026-03-03 | English | ||
| 29143910 | 4 Filing | 2026-02-13 | English | ||
| 29143925 | SCHEDULE 13G/A Filing | 2026-01-16 | English | ||
| 29143905 | 4 Filing | 2026-01-16 | English | ||
| 29143938 | 8-K Filing | 2026-01-09 | English | ||
| 29143920 | 4 Filing | 2026-01-09 | English | ||
| 29143912 | 4 Filing | 2026-01-09 | English | ||
| 29143909 | 4 Filing | 2026-01-09 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Tango Therapeutics, Inc.
A clinical-stage biotech developing precision oncology medi…
|
TNGX | US | Professional, scientific and te… |
|
Taysha Gene Therapies, Inc.
Clinical-stage company developing AAV-based gene therapies …
|
TSHA | US | Professional, scientific and te… |
|
Technical Ventures RX Corp.
Develops and commercializes autologous cell therapies for t…
|
— | CA | Professional, scientific and te… |
|
Tectonic Therapeutic, Inc.
Clinical-stage biotech developing biologics targeting G-Pro…
|
TECX | US | Professional, scientific and te… |
|
Telo Genomics Corp.
Quantifies genomic instability via telomere 3D structure to…
|
TELO | CA | Professional, scientific and te… |
|
Telomir Pharmaceuticals, Inc.
Pre-clinical pharma company developing a small molecule for…
|
TELO | US | Professional, scientific and te… |
|
Tempest Therapeutics, Inc.
Clinical-stage oncology company developing small molecule a…
|
TPST | US | Professional, scientific and te… |
|
Terns Pharmaceuticals, Inc.
Clinical-stage biopharma developing small-molecule drugs fo…
|
TERN | US | Professional, scientific and te… |
|
TERRAGEN HOLDINGS LIMITED
Develops microbial technology to enhance animal health and …
|
TGH | US | Professional, scientific and te… |
|
Tevogen Bio Holdings Inc.
Clinical-stage immunotherapy company developing off-the-she…
|
TVGN | US | Professional, scientific and te… |
ANAPTYSBIO, INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32596/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32596 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32596 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32596 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32596}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ANAPTYSBIO, INC (id: 32596)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.